Microtubules, schizophrenia and cognitive behavior: Preclinical development of davunetide (NAP) as a peptide-drug candidate

Illana Gozes*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Microtubules, schizophrenia and cognitive behavior: Preclinical development of davunetide (NAP) as a peptide-drug candidate'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry